Article: VERONA PHARMA PLC - Further re Board Appointment.

 
  11 September 2009 
 
   Verona Pharma plc 
 
  ("Verona Pharma" or the "Company") 
 
 Further re: Board Appointment 
 
Further to the announcement earlier today of the appointment of Dr Patrick 
Humphrey and a grant of options to him, the exercise price of Dr Humphrey's 
option has been determined at 17.5 pence per Verona Pharma ordinary share. 
 
--END-- 
 
 
 
For more information please contact: 
 
Professor Clive Page07971 504 931 
Chairman, Verona Pharma plc 
 
Barry Saint / Tim ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!